Views & Analysis Why AI and blockchain are the solutions to developing orphan... We are in the midst of a significant shift in pharmaceutical drug development, with many leading companies focusing increasingly on orphan drugs targeted at small niche markets.
Views & Analysis Why blockchain is a dream come true for pharma researchers Researchers tend to have a genuine scientific curiosity and desire to make the world better with their discoveries.
Views & Analysis Four steps to building an innovation culture in pharma The quest for innovation is a major driving force in pharma.
Views & Analysis How blockchain will revolutionise clinical trials The risky and unpredictable nature of the clinical trial process is a major driver of high costs for pharmaceutical drugs.
Views & Analysis To unlock innovation, pharma needs to be honest about failur... Many successful leaders agree that a company’s willingness to embrace and learn from failure can unlock inn
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.